Pembrolizumab is a humanized monoclonal antibody directed at programmed death-1 (PD-1) receptor, a negative regulator of T-cell activity. Pembrolizumab potentiates T-cell responses, including anti-tumour responses.

What can Sanquin do for you?

  • Measure drug levels of free drug in the serum using an validated ELISA.
  • Measure the immunogenicity of pembrolizumab.
  • Provide assay reagents or co-develop novel testing strategies.
  • Folllowing ISO, FDA/EMA, RUO guidelines.

Enquire about our drug level and ADA assays by emailing us at [email protected].